SCHEMBL30424730

SCHEMBL30424730

CSCC[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C

nearest known ligand 0.53

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ C5AR1 P21730 1/20 0.53
▸ TFPI P10646 1/20 0.53
▸ NPY4R P50391 6/20 0.53
▸ NPY1R P25929 5/20 0.53
▸ NPY2R P49146 4/20 0.53
▸ NPY5R Q15761 4/20 0.53
▸ GLP1R P43220 6/20 0.52
▸ SCTR P47872 1/20 0.52
▸ GCGR P47871 3/20 0.51
▸ CALCR P30988 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31410833 0.95 TFPI (0.56) TFPIGLP1RSCTRGCGRCALCR
SCHEMBL29697191 0.92 NPY4R (0.51) TFPINPY4RNPY1RNPY2RNPY5R
SCHEMBL31307236 0.91 TFPI (0.57) TFPIGLP1RSCTRGCGRCALCR
SCHEMBL31461903 0.88 CALCR (0.61) TFPIGLP1RSCTRGCGRCALCR
SCHEMBL30883206 0.88 TFPI (0.61) TFPIGLP1RSCTRGCGRCALCR
SCHEMBL5500011 0.88 C5AR1 (0.58) C5AR1TFPINPY4RNPY1RNPY2R
SCHEMBL5500020 0.88 C5AR1 (0.58) C5AR1TFPINPY4RNPY1RNPY2R
SCHEMBL11123257 0.88 C5AR1 (0.47) C5AR1GLP1RGCGR
SCHEMBL11123246 0.88 C5AR1 (0.47) C5AR1GLP1RGCGR
SCHEMBL29469826 0.87 KEAP1 (0.54) C5AR1TFPIGLP1RSCTRGCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023090935-A1 METHOD FOR PRODUCING AGM PEPTIDES THAT BIND SPECIFICALLY TO NUCLEOLIN 애니젠 주식회사 2023-05-25 — — WO claimed
WO-2023090935-A1 METHOD FOR PRODUCING AGM PEPTIDES THAT BIND SPECIFICALLY TO NUCLEOLIN 애니젠 주식회사 2023-05-25 — — WO disclosed
Send feedback